Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can probiotic gummies soothe Kids' allergies?

NCT ID NCT06676111

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study tested whether probiotic gummies can relieve allergic rhinitis symptoms in children aged 4 to 14. Over 56 days, 72 kids took either the probiotic or a placebo, and researchers tracked nasal symptoms, quality of life, and gut health. The goal was to see if probiotics offer a safe, natural way to ease allergy discomfort.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
probiotic gummies
What this could lead to
If it works, this could offer a simple, natural option to help ease allergy symptoms in children.
What could go wrong
This is a small, completed trial with 72 children, so results may not apply to everyone. Probiotics are generally safe but may not work for all kids.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

72 people

The number who actually took part.

Started

Oct 2024

Finished

Jul 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

4 to 14 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Voluntary, written, and signed informed consent form, agreeing to participate in this study; 2. Capable of completing research according to the requirements of the experimental plan; 3. Age range: 4-14 years old; 4. Meets the diagnostic criteria for AR established in the "Guidelines for Diagnosis and Treatment of Allergic Rhinitis in Children (Revised 2022)"; 5. Symptoms: Two or more symptoms appear: sneezing, watery nasal discharge, nasal itching, and nasal congestion. Symptoms last or accumulate for more than 1 hour per day, and may be accompanied by eye symptoms such as itching, tearing, and redness; 6. Physical signs: pale and edematous nasal mucosa, accompanied by watery discharge. Exclusion Criteria: 1. Drugs that affect the intestinal flora (including antibacterial drugs, probiotics, intestinal mucosal protective agents, traditional Chinese patent medicines and simple preparations, etc.) are continuously used for more than one week within one month before screening; 2. Merge with tuberculosis patients; 3. Combined with allergic asthma; 4. Patients with nasal polyps or severe nasal septum deviation; 5. Patients with serious systemic diseases or malignant tumors; 6. Individuals with congenital genetic disorders or congenital immunodeficiency diseases; 7. Regular use of probiotics or prebiotics within the first 6 months of the screening period; 8. Individuals with severe gastrointestinal diseases (including severe diarrhea, inflammatory bowel disease, etc.); 9. Those with metabolic syndrome (including obesity, abnormal lipid metabolism, hypertension, diabetes, etc.); 10. Patients with combined sinusitis, otitis media, or respiratory infections; 11. Stop taking the test sample or add other drugs midway, unable to determine efficacy or incomplete data; 12. Short term use of substances with similar functions to the test subject affects the judgment of the results; 13. The subject is unable to participate in the trial due to personal reasons; 14. Participants deemed unsuitable by other researchers to participate. Those who meet any of the above conditions shall not be selected.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Children with allergic rhinitis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Henan University of Science and Technology

    Luoyang, Henan, 471000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.